Vascular endothelial growth factor is essential for hyperglycemia-induced structural and functional alterations of the peritoneal membrane

Journal of the American Society of Nephrology

Volumn 12, Issue 8, 2001, Pages 1734-1741

  De Vriese, A S ^a   Tilton, R G ^a   Stephan, C C ^a   Lameire, N H ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; MEMBRANE PERMEABILITY; NONHUMAN; PATHOGENESIS; PERITONEAL DIALYSIS; PERITONEUM; PRIORITY JOURNAL; RAT;

EID: 0034918995     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Longitudinal changes in peritoneal kinetics: The effects of peritoneal dialysis and peritonitis
2. Functional longevity of the human peritoneum: How long is continuous peritoneal dialysis possible? Results of a prospective medium long-term study
3. Peritoneal vascular changes in continuous ambulatory peritoneal dialysis (CAPD): An in vivo model for the study of diabetic microangiopathy
4. Categorization of ultrastructural changes in peritoneal mesothelium, stroma and blood vessels in uremia and CAPD patients
5. Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis
6. Increased capillary permeability in diabetes mellitus and its relationship to microvascular angiopathy
7. Microangiopathy in diabetes mellitus: II. Features, complications and investigation
8. Structure-function relationships associated with extracellular matrix alterations in diabetic glomerulopathy
9. Role of vascular endothelial growth factor in the regulation of angiogenesis
10. Vascular endothelial growth factor and its receptors
11. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
12. Role for nitric oxide in the hyperpermeability and hemodynamic changes induced by intravenous VEGF
13. VEGF induces NO-dependent hyperpermeability in coronary venules
14. Effects of high glucose on vascular endothelial growth factor expression in vascular smooth muscle cells
15. Glucose-induced protein kinase C activation regulates vascular permeability factor mRNA expression and peptide production by human vascular smooth muscle cells in vitro
16. Vascular endothelial growth factor is induced by long-term high glucose concentration and up-regulated by acute glucose deprivation in cultured bovine retinal pigmented epithelial cells
17. Vascular endothelial growth factor and vascular permeability changes in human diabetic retinopathy
18. Vascular endothelial growth factor and its receptors in control and diabetic rat eyes
19. Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes
20. Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195
21. Vascular endothelial growth factor expression in peripheral nerves and dorsal root ganglia in diabetic neuropathy in rats
22. Growth factors VEGF and TGF-beta1 in peritoneal dialysis
23. Vascular dysfunction induced by elevated glucose levels in rats is mediated by vascular endothelial growth factor
24. A simple kinetic model for assessing peritoneal mass transfer in chronic ambulatory peritoneal dialysis
25. Computer simulations of peritoneal fluid transport in CAPD
26. Off-line analysis of red blood cell velocity in renal arterioles
27. Dimensions of blood vessels from distributing artery to collecting vein
28. N-acetylcysteine attenuates endotoxin-induced leukocyte-endothelial cell adhesion and macromolecular leakage in vivo
29. Increased peritoneal permeability to albumin in streptozotocin diabetic rats
30. Reactive oxygen species and acute modulation of albumin microvascular leakage in the microcirculation of diabetic rats in vivo
31. Receptormediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats
32. Prevention of hemodynamic and vascular albumin filtration changes in diabetic rats by aldose reductase inhibitors
33. Vascular endothelial growth factor/vascular permeability factor produces nitric oxide-dependent hypotension. Evidence for a maintenance role in quiescent adult endothelium
34. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: Significance for VEGF measurements and cancer biology
35. Glucose degradation product methylglyoxal enhances the production of vascular endothelial growth factor in peritoneal cells: Role in the functional and morphological alterations of peritoneal membranes in peritoneal dialysis
36. Advanced glycation end products increase retinal vascular endothelial growth factor expression
37. Targeting vascular endothelial growth factor (VEGF) for anti-tumor therapy, by anti-VEGF neutralizing monoclonal antibodies or by VEGF receptor tyrosine-kinase inhibitors